Alto Neuroscience Funding & Investors

Los Altos, CA

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Total Amount Raised: $239,261,808

IPO
Unknown
Jan 1, 2024
Series C
$45,000,000
Nov 20, 2023
Series C Investors
InVivium Capital
Lightswitch Capital
Windham Venture Partners
Eli Lilly
Franklin Resources
What If Ventures
Alkeon Capital Management
Alexandria Venture Investments
Point72 Ventures
Alpha Wave Ventures
Series B
$25,000,000
Jan 29, 2023
Series B Investors
Alpha Wave Ventures
THE CATALYTIC IMPACT FOUNDATION (CIF)
Debt Financing
$35,000,000
Jan 29, 2023
Debt Financing Investors
K2 HealthVentures
Series B
$35,000,000
Oct 24, 2022
Series B Investors
Alkeon Capital Management
Lightswitch Capital
What If Ventures
Sobrato Capital
Apeiron Investment Group
Vine Ventures
Windham Venture Partners
Novartis Pharma
Korify Capital
Gaingels
Valor Equity Partners
Presight Capital
infinitas capital
Series Unknown
$59,261,815
Apr 5, 2022
Series A
$32,000,000
May 2, 2021
Series A Investors
Apeiron Investment Group
Presight Capital
Stanford University
Risk and Return
What If Ventures
Able Partners
Windham Venture Partners
Tim Kendall
Korify Capital
Arda Kara
PsyMed Ventures
Seed
$8,000,000
Sep 18, 2019
Seed Investors
Tim Kendall

Funding info provided by Diffbot.